Recent studies have revealed STAT3 as a major player in the regulation of innate and adaptive tumor immunity and as a therapeutic target to enhance immune recognition and to break T cell tolerance of tumor cells [18,70]. This evidence concerns the gene STAT3 and neoplasm.